Brain Longevity® in the Workplace: How to Maximize Your Resilience during COVID-19

Presentation description:

Dementia is a leading cause of disability worldwide. In the United States there are nearly 6 million people living with Alzheimer’s dementia and this number is expected to more than double by mid-century. Changes in the brain can occur many years before the symptoms appear and many experts report that lifestyle factors impact our brain and the risk for developing dementia.

In this presentation we will discuss the difference between dementia and Alzheimer’s disease and how Alzheimer’s disease affects the brain. Modifiable and non- modifiable risk factors will be presented along with current evidence supporting brain health and the reduction of the risk of developing dementia. The four key areas emphasized in the Brain Longevity® Therapy Program developed by the Alzheimer’s Research & Prevention Foundation will be discussed. This includes exercise, diet and supplements, stress management, and spiritual fitness.

Finally, strategies to redesign your lifestyle and optimize habits and routines, especially during COVID-19 will be discussed.

About our speaker:

Presenters:

Patricia Cornille OTD, OTR/L, CCEL

Dr. Patricia Cornille is a passionate expert in understanding the connection of the brain and everyday behavior. She is the founder and clinical director of Vita Cura Services and the president of the Global Action Coalition for Dementia, Mental Health and Cognitive Disability. Both organizations provide high quality services for individuals living with or at risk for living with cognitive change.

Dr. Cornille received her doctorate at Creighton University where she focused on dementia care and lifestyle medicine, studied occupational science at the Karolinska Institute, and is a graduate of the Brain Longevity® Therapy Training Program through the Alzheimer’s Research and Prevention Foundation.